Most company are walking away from Patent cliff. I think this create a great opportunity for small pharma.

However, this also mean the supplier of big pharma is going to have to find a need way to lower their cost since their profit margin of their products are less profitable.

via Sanofi CEO targeting everything but blockbusters –